| 33.57 0.15 (0.45%) | 04-24 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 42.06 | 1-year : | 45.71 |
| Resists | First : | 36.01 | Second : | 39.13 |
| Pivot price | 32.61  |
|||
| Supports | First : | 30.95 | Second : | 25.75 |
| MAs | MA(5) : | 32.89 |
MA(20) : | 33.58 |
| MA(100) : | 50.06 |
MA(250) : | 69.62 |
|
| MACD | MACD : | -1.6 |
Signal : | -2 |
| %K %D | K(14,3) : | 50.6 |
D(3) : | 35.8 |
| RSI | RSI(14): 44.1 |
|||
| 52-week | High : | 109.51 | Low : | 30.95 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ MED ] has closed below upper band by 20.8%. Bollinger Bands are 70.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 33.85 - 33.98 | 33.98 - 34.11 |
| Low: | 32.31 - 32.47 | 32.47 - 32.62 |
| Close: | 33.32 - 33.56 | 33.56 - 33.8 |
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
Sat, 30 Mar 2024
While shareholders of Medifast (NYSE:MED) are in the red over the last three years, underlying earnings have actually ... - Simply Wall St
Thu, 14 Mar 2024
Should You Think About Buying Medifast, Inc. (NYSE:MED) Now? - Yahoo Finance
Tue, 12 Mar 2024
Director Scott Schlackman Sells Shares of Medifast Inc (MED) - Yahoo Finance
Thu, 07 Mar 2024
Medifast Is Getting Attractive (NYSE:MED) - Seeking Alpha
Fri, 23 Feb 2024
Analysts Are More Bearish On Medifast, Inc. (NYSE:MED) Than They Used To Be - Yahoo Finance
Thu, 22 Feb 2024
Medifast, Inc.'s (NYSE:MED) 26% Dip In Price Shows Sentiment Is Matching Earnings - Simply Wall St
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Cyclical
|
|
|
Industry:
Personal Products & Services
|
|
| Shares Out | 11 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 2.7 (%) |
| Held by Institutions | 97.7 (%) |
| Shares Short | 2,660 (K) |
| Shares Short P.Month | 1,940 (K) |
| EPS | 9.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.69 |
| Profit Margin | 9.2 % |
| Operating Margin | 4.5 % |
| Return on Assets (ttm) | 25.2 % |
| Return on Equity (ttm) | 55.7 % |
| Qtrly Rev. Growth | -43.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 98.16 |
| EBITDA (p.s.) | 12.79 |
| Qtrly Earnings Growth | -77.4 % |
| Operating Cash Flow | 148 (M) |
| Levered Free Cash Flow | 106 (M) |
| PE Ratio | 3.68 |
| PEG Ratio | 0.8 |
| Price to Book value | 1.79 |
| Price to Sales | 0.34 |
| Price to Cash Flow | 2.47 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|